COST
48
-2
NDAQ
55
10
ORCL
33
4
FOX
11
5
UNP
48
2
V
38
2
KMI
73
2
TJX
55
2
MPC
70
5
IR
46
2
BWA
59
-2
CTAS
39
3
SIG
82
4
TROW
34
2
APH
53
-5
HRL
27
-2
NSC
64
2
TGT
48
-2
EL
67
11
CI
59
14
COST
48
-2
NDAQ
55
10
ORCL
33
4
FOX
11
5
UNP
48
2
V
38
2
KMI
73
2
TJX
55
2
MPC
70
5
IR
46
2
BWA
59
-2
CTAS
39
3
SIG
82
4
TROW
34
2
APH
53
-5
HRL
27
-2
NSC
64
2
TGT
48
-2
EL
67
11
CI
59
14
Financhill
Back

Roche Holding AG 10K Form

Sell
49

RHHVF
Roche Holding AG

Last Price:
$482.87
Seasonality Move:
1.54%

7 Day Trial

ALL ACCESS PASS

$ 7

Key Filings

10K form not available

Receive RHHVF News And Ratings

See the #1 stock for the next 7 days that we like better than RHHVF

RHHVF Financial Statistics

Sales & Book Value

Annual Sales: $74.1B
Cash Flow: $0
Price / Cash Flow: 25.58
Annual Sales: $45.10
Price / Book: 6.8

Profitability

EPS (TTM): 19.22040
Net Income (TTM): $16.5B
Gross Margin: $54.5B
Return on Equity: 28.65%
Return on Assets: 10%

Roche Holding AG Earnings Forecast

Key Roche Holding AG Financial Ratios

  • The Gross Profit Margin over the past 46 years for RHHVF is 73.53%.
  • The Selling, General & Administrative Expenses for RHHVF have been equal to 24.65% of Gross Profit Margin.
  • The Research & Development expenses have been 19.83% of Revenue.
  • The Interest Expense is 8.60% of Operating Income.
  • The Net Earning history of RHHVF is 22.43% of Total Revenues.
  • Per Share Earnings over the last 46 years have been positive in 33 years.

Roche Holding AG Stock Price Chart

Industry, Sector and Symbol

Stock Exchange: OTCM
Industry: Pharmaceuticals
Sector: Health Care
Current Symbol: RHHVF
Website: roche.com

Debt

Debt-to-Equity Ratio: 1.15
Current Ratio: 1.29
Quick Ratio: 0.88

Price-to-Earnings

Trailing P/E Ratio: 24.85
Forward P/E Ratio: 0

RHHVF Technical Analysis vs Fundamental Analysis

Sell
49
Roche Holding AG (RHHVF) is a Sell

Is Roche Holding AG a Buy or a Sell?

  • Roche Holding AG stock is rated a Sell
    The current Roche Holding AG [RHHVF] share price is $480.00. The Score for RHHVF is 49, which is 2% below its historic median score of 50, and infers higher risk than normal.